[1]
“COMPARISON OF SARS-COV-2 ANTIBODY PRODUCTION BY 2-DOSE CORONAVAC, 2-DOSE VAXZEVRIA, 2-DOSE CORONAVAC-VAXZEVRIA HETEROLOGOUS VACCINATION AND POST-INFECTION”, SEATROPH, vol. 52, no. 5, pp. 689–695, Oct. 2021, Accessed: Apr. 16, 2026. [Online]. Available: https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/532